Alpha 1 Antitrypsin Deficiency Treatment Market Analysis of Current and Future Industry Trends and Growth till 2027
Alpha-1 antitrypsin deficiency (AATD) is a hereditary condition characterized by low levels of alpha-1 antitrypsin (AAT) protein in the blood, leading to an increased risk of lung and liver diseases. AATD primarily affects the lungs, predisposing individuals to chronic obstructive pulmonary disease (COPD), emphysema, and other respiratory complications. The AATD treatment market encompasses a...
0 Comments 0 Shares 39 Views 0 Reviews